← Open Payments lookup

PABLO PROANO: Open Payments

NPI 1639109036 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,577 in 167 payments from 15 companies in 2025. Trend: 2023 $13,405 · 2024 $5,831 · 2025 $5,577

Food & beverage: $5,577
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$1,192
Axsome Therapeutics, Inc.13$680
Neurocrine BioSciences, Inc.13$630
Alkermes, Inc.14$521
ABBVIE INC.23$499
Teva Pharmaceuticals USA, Inc.13$443
Vanda Pharmaceuticals Inc.9$417
E.R. Squibb & Sons, L.L.C.7$358
Supernus Pharmaceuticals, Inc.19$306
Otsuka America Pharmaceutical, Inc.6$213

Products named: CAPLYTA, Auvelity, INGREZZA, VRAYLAR, FANAPT, COBENFY, AUSTEDO XR, Qelbree.

Industry payments across WA — which companies pay providers there.